Initially, we selected the MOLT4 cell line (T cell lymphoma) for these studies, confirming the high level hMCAM expression reported in the literature (FACS detection with anti-MCAM more than 10-fold above isotype control, data not shown). This evidence concerns the gene MCAM and T-cell non-Hodgkin lymphoma.